Connect with us

Business

Aurora Cannabis Inc (NYSE:ACB) Sets Out for Global Domination with ICC Move

Published

on

Aurora Cannabis Inc (NYSE:ACB) continues to pull back, dropping about 50% off its highs. However, the stock is still up over 250% in the past year. Like Canopy, this is a long game in play for Aurora. Think of the old board game “Risk”. The world is a big map of the territory to be won or lost if you believe, like the management teams at these two companies believe, that we are on a path to see most of the world gradually start to increasingly legalize cannabis.

The science is increasingly supportive of this move, and the world has gotten smaller and smaller in terms of cultural differentiation with the advent of a global fiber optic IT infrastructure in the late 1990’s. The result is increasing homogenization of views on many things, with cannabis being part of that equation. So, given this outlook on the world, what is the goal of the strategic vision of one of the best and biggest, and most well-capitalized, cannabis players?

Aurora Cannabis Inc (NYSE:ACB) is one of the most widely diversified players in the cannabis space due to its powerful strategic investments.

And that status has just been further augmented with the company’s recent announcement that Aurora has received consent and approval from its consortium of lenders led by Bank of Montreal to move forward with the acquisition of all of the issued and outstanding common shares of ICC Labs Inc. (ICC), a fully licensed producer and distributor of medicinal cannabinoid extracts, recreational cannabis, and industrial hemp products in Uruguay as well as a fully licensed producer of medicinal cannabis in Colombia.

In other words, Aurora is setting up camp in a big way in the South American market.

Think of that risk board again. This is a territorial race between several of the biggest players, including Aurora and Canopy as probably the frontrunners, then perhaps, Aphria and several others. We would see Tilray as somewhere just outside of the top ten on this list (despite the company’s somewhat baseless attempts to hype itself as some sort of leading player in the space).

Aurora Cannabis Inc (NYSE:ACB) managed to rope in revenues totaling $19.1M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 222.6%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($149.4M against $75.2M).

As noted in the release detailing the strategic rationale behind the acquisition, Aurora states that this deal “will create a strong foundation for expansion, and will leverage ICC’s first-mover advantage in South America, bringing significant low-cost production capacity, a well-diversified product portfolio, and extensive distribution channels throughout South America and internationally. Led by CEO Alejandro Antalich, a widely-recognized leader in the South American cannabis market with over 25 years of experience in the pharmaceutical sector, the acquisition of ICC will establish Aurora as the industry leader in South America, a continent with over 420 million people.  ICC is based in Uruguay, the first country in the world to legalize cannabis for adult consumer use. In addition, ICC holds licenses in Colombia for the production of medical cannabis.”

 

Knowledge is Power

Aurora Cannabis Inc (NYSE:ACB) has demonstrated rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies – MedReleaf, CanvasRX, Peloton Pharmaceutical,  Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending acquisition of ICC Labs.

We would also note that the company has invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).

However, just drilling down into its core cannabis production operations, Aurora Cannabis Enterprises Inc, trumpets itself as “one of the world’s largest and leading cannabis companies” and a licensed producer of medical cannabis pursuant to ACMPR.

We would expect expansion on the way given the inflow of investment capital. But, at present, the Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as Aurora Mountain, is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal’s West Island.

Business

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Subsidiary’s Cannabis Product Performs Remarkably

Published

on

By

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is an industry leader in the development of cannabinoid-based therapies. Some of this company’s leading products help treat a wide range of medical disorders and conditions.

Nature of the research

This company’s subsidiary, One World Cannabis, has been researching its Medical Grade Cannabis. It has unveiled the results of the research terming them Top Line. This was a single-dose, randomized, crossover study that sought to compare several aspects of the medical solutions. Among them included the safety, tolerability, and pharmacokinetics (PK) of the buccal Sativex® versus the Orally Disintegrating Tablets (MGC-ODT). Some of the elements to be studied include THC, THC metabolite 11-hydroxy-THC, and CBD. An official working with OWC Pharmaceutical Research Corp says that the research involved some healthy adult volunteers.

This research was conducted at the Sourasky Medical Center, which is situated in Tel Aviv. The study will help deliver top-notch products to consumers on a nationwide scale and even beyond borders.

One of the lede researchers reveals that the persons participating in the study were administered randomly. As outlined earlier, the products in question were OWC-ODT (4.2 mg THC, 5 mg CBD) and Sativex (5.4 mg THC, 5.0 mg CBD). The study also involved a two weeks cross over period.

Results of the study

 The researcher also revealed that after 24 hours of the product administration, plasma would be collected from the volunteers. The other thing would be to monitor the effects of the products, and then the researchers would go to the next step. Probably, that would be the checking out as well as the quantification of the THC, CBD, and 11-OH-THC concentrations. The determination of the plasma PK will be important in writing down the final report.

The TLR indicates that both the administration of both MGC-ODT and Sativex® pulled along with rather similar mean times. This was specifically in terms of half-life, peak concentration, and eventually, the elimination rates.

One unique aspect of the results is how they showed some dose-related comparability for the products in terms of bioavailability and absorption. Another important point worth noting is that the treatment incidence showed the related adverse events (AEs), indicating a lot of similarities between the administered treatments.

Continue Reading

Business

Glance Technologies Inc (OTCMKTS:GLNNF) Communicates To Shareholder Through A Letter

Published

on

Glance Technologies Inc (OTCMKTS:GLNNF) owns the dynamic mobile payment and loyalty technology platform known as Glance Pay®. Today, the CEO of the company Jonathan Hoyles has written a letter to the shareholder in the company. This is the first letter the official is writing to them in the position of the company’s Interim CEO.

Hoyles and his words for shareholders

Hoyles wants all shareholders to understand everything regarding the operations and plans. Through this letter, shareholders get to understand what the company intends to over the coming six to twelve months.

The company’s CEO discloses that a short while back, they set some clear measures and goals to help the company move forward. The target is to achieve the set goals within a short time. Some analysts that have had the opportunity to read through these goals see them as overly ambitious.

However, Hoyles exudes confidence saying that they have a dependable team in place. According to the official, this is crucial towards the achievement of the company’s set goals. The leader is quick to admit that indeed, progress is a matter that calls for a company’s dedication to taking the necessary risks. He urges everyone, including the shareholders, in the company, to give their support so that they achieve a home run.

Research and developmental plans

In recent times, the company has directed some funds into quantitative and qualitative market research. Some of the activities it has found helpful include merchant interviews, end-user surveys, and external research. One thing coming out pretty clearly is the fact that most of the end-users seek to be rewarded for their continued loyalty to the company and its diverse products.

Asides from this, they are calling out to the company to move with speed in setting up more restaurant locations for them. It is worth noting that users greatly appreciate the company’s support in helping them pay bills easily and quickly. However, the company thinks it needs to do more than offer them convenience. It wants to move a step further to give them suggestions on items that they need to try out.

Further improvements will be made in marketing and branding, sales and distribution, and also in the enhancement of customer experience. Howles says that they will focus on the right priorities. To him, the best thing is for the company to move its resources to areas of greater yield and productivity.

Continue Reading

Business

Green Organic Dutchman Holdings (OTCMKTS:TGODF) To Review Financing Alternatives For Construction Purposes

Published

on

Green Organic Dutchman Holdings (OTCMKTS:TGODF) has, over the years, been focusing on the production of premium organic cannabis products. The business guru has today disclosed details about its credit financing. According to its spokesperson, the company needs to complete the construction of a number of its business facilities. The facilities are in Ontario, Ancaster, and Phase 1a at Valleyfield, Quebec. Lately, the business has been reviewing some financial alternatives to see the ones to settle for.

The turn of events

In a statement, the company has revealed that the market conditions have been very dynamic and thus need from proper planning. It has, in the past, held discussions regarding some commercial bank facilities and equipment leasing in a bid to identify what would work. The company admits that the discussions were fruitful since it was able to chart the way forward. However, the main point of the discussion wasn’t arrived at. That was because most of the financing sources turned out to be inappropriate. The company says that most of them did not match the required timeframes. It says it had no otherwise but to start reviewing other alternatives.

Plans moving forward

The completion of these facilities is a costly undertaking, but the company seems quite determined.

An official working with The Green Organic Dutchman Holdings but who wanted his identity kept anonymous has made a point. He says that the company, at the moment, has no debt. However, it has about $56.7 million available in cash in Canada. It also has some $40.2 million that will take care of the company’s capital expenditures. The construction activities at the Ancaster are almost reaching completion according to sources. The business giant says that in a matter of about 6-weeks, it will have completed the construction activities here.

Green Organic Dutchman Holdings is optimistic it will get the financing that it requires. In that particular regard, it will channel the funds towards accelerating its commercial production. The goal is to increase its revenues by a significant margin.

So far, the company has gotten into several supply agreements. Some of them are with Alberta, British Columbia, and Ontario. The deal is to engage in the distribution of products on a nationwide scale.

Continue Reading
Advertisement

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade


FEATURED STORIES

Business21 hours ago

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Subsidiary’s Cannabis Product Performs Remarkably

Post Views: 178 OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is an industry leader in the development of cannabinoid-based therapies. Some of...

Business22 hours ago

Glance Technologies Inc (OTCMKTS:GLNNF) Communicates To Shareholder Through A Letter

Post Views: 68 Glance Technologies Inc (OTCMKTS:GLNNF) owns the dynamic mobile payment and loyalty technology platform known as Glance Pay®....

Business2 days ago

Green Organic Dutchman Holdings (OTCMKTS:TGODF) To Review Financing Alternatives For Construction Purposes

Post Views: 138 Green Organic Dutchman Holdings (OTCMKTS:TGODF) has, over the years, been focusing on the production of premium organic...

Business2 days ago

HEXO (OTCMKTS:HYYWF) Expects To Post Net Revenues Of $16.5 Million in Q4 2019 And $48.5 Million For FY 2019

Post Views: 133 HEXO (OTCMKTS:HYYWF) expects to post net revenues of up to $16.5 million in Q4 2019. The company...

Business5 days ago

LeafBuyer Technologies Inc. (OTCMKT:LBUY) Reports 59% YoY Growth In Revenue Following Optimization Of Its Platforms

Post Views: 219 LeafBuyer Technologies Inc. (OTCMKT:LBUY) has announced that its annual revenue for FY 2019 grew by 59%, reflecting...

Business5 days ago

High Tide Inc. (OTCMKTS:HITIF) Report Impressive Q3 Financial Results with Revenue Growing 281%

Post Views: 172 High Tide Inc. (OTCMKTS:HITIF) has announced an inspiring financial result for its third quarter of 2019. The...

Business6 days ago

Kalytera Therapeutics Inc (OTCMKTS:KALTF) Provides Details About Its Latest Notice Of Allowance

Post Views: 156 Kalytera Therapeutics Inc (OTCMKTS:KALTF) has today revealed details regarding the EU Patent Application Number 14791611.8. According to...

Business6 days ago

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Engages Cellular Biologist David A. Judd In An Interview

Post Views: 835 Pharmacyte Biotech Inc (OTCMKTS:PMCB) uses its live-cell encapsulation technology known as Cell-in-a-Box®  for the treatment of diabetes...

Business7 days ago

CV Sciences Inc (OTCMKTS:CVSI) enters a Distribution Agreement With Harris Teeter

Post Views: 150 CV Sciences Inc (OTCMKTS:CVSI) today announced its business collaboration with Harris Teeter. These two business giants target...

Business7 days ago

Tetra Bio Pharma Inc (OTCMKTS:TBPMF) Speaks Out On Its CAUMZ(TM) Kit

Post Views: 160 Tetra Bio Pharma Inc (OTCMKTS:TBPMF) is one of the leaders in the cannabinoid-based therapeutics sector. Some of...

Whats Hot

CULTIVATING

SHAREHOLDER VALUE

 

Trading Symbol

CSE: CHOO
OTCQB: CHOOF

Choom Holdings Inc. CSE: CHOO | OTCQB: CHOOF